Skip to main content
Caplight Logo









Pendrea Bio, Inc.

Pendrea Bio, Inc.

Private
Boalsburg, PennsylvaniaHealthcare & Life Scienceshttps://grokipedia.com/

Last Round

Series A

Oct 1, 2020

Total Funding Raised

$4.5M

Company Overview

Pendrea Bio, Inc. is a biotechnology company that develops nanotechnology platforms, including calcium-phosphate NanoJackets for RNA therapeutics and photo-immuno nano therapy for oncology applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

nanotechnologydrug deliverynanomedicineoncology therapeuticsRNA therapeuticsprecision medicinenanoparticle platformsolid tumor treatmentgene therapyclinical-stage biotechbiotech startupdrug developmentSBIR grantsnon-dilutive funding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pendrea Bio, Inc. Comparables

Compare Pendrea Bio, Inc. with similar companies based on industry and business-model similarity.

Pendrea Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cello Therapeutics
79%
TransCode Therapeutics, Inc.
79%
Duo Oncology
79%

Pendrea Bio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 1, 2020
SeedOct 1, 2020
GrantOct 5, 2015

Pendrea Bio, Inc. Investors

Notable investors and investment history

Pendrea Bio, Inc. investors
InvestorRounds
National Cancer InstituteGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2020

    $20M round completed.

Pendrea Bio, Inc. Filings

Explore SEC and related filing metadata, where available.

Pendrea Bio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pendrea Bio, Inc.'s valuation, stock price, and market status.

Is Pendrea Bio, Inc. a public or private company?

Pendrea Bio, Inc. is a private company.

What is the current stock price of Pendrea Bio, Inc.?

Pendrea Bio, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Pendrea Bio, Inc. worth (valuation)?

Valuation information for Pendrea Bio, Inc. is not publicly available.

Can I buy Pendrea Bio, Inc. stock?

Pendrea Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pendrea Bio, Inc.'s last funding round?

Funding round information for Pendrea Bio, Inc. is not publicly available.

Who are the main investors in Pendrea Bio, Inc.?

Investor information for Pendrea Bio, Inc. is not publicly disclosed.

Will Pendrea Bio, Inc. IPO soon?

No public IPO plans have been announced for Pendrea Bio, Inc..

How can I track Pendrea Bio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pendrea Bio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoalsburg, Pennsylvania
Employee Range1
Year Founded2005
Last FundingOct 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?